IL5 and neoplasm: The differences of eosinophils influx between mice with gastrointestinal cancers treated with recombinant IL-5 and Th2 cells may be related with the innate anti-tumorigenic immune response amplified by directly recruiting immune cells into tumor and with more complex action of Th2 cells, which participate not only to eosinophils activation but also macrophage activity.